Time of progression to type 2 diabetes study period [clinicaltrials_resource:30fe7fd19c58b874fc4846f9b760a3f4]

Time of progression to type 2 diabetes study period [clinicaltrials_resource:30fe7fd19c58b874fc4846f9b760a3f4]

oral administration once daily
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:30fe7fd19c58b874fc4846f9b760a3f4
Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes (RAPSODI) [clinicaltrials:NCT00325650]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Time of progression to type 2 diabetes study period [clinicaltrials_resource:30fe7fd19c58b874fc4846f9b760a3f4]

oral administration once daily
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:30fe7fd19c58b874fc4846f9b760a3f4
Bio2RDF identifier
30fe7fd19c58b874fc4846f9b760a3f4
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:30fe7fd19c58b874fc4846f9b760a3f4
measure [clinicaltrials_vocabulary:measure]
Time of progression to type 2 diabetes
time frame [clinicaltrials_vocabulary:time-frame]
description
oral administration once daily
identifier
clinicaltrials_resource:30fe7fd19c58b874fc4846f9b760a3f4
title
Time of progression to type 2 diabetes study period
@en
inDataset
type
label
Time of progression to type 2 ...... e7fd19c58b874fc4846f9b760a3f4]
@en